Evidence map›Paper›PMID 32850827›Full record

ArticleFrontiers in cell and developmental biology2020

Crude Cell-Free Extract From

Illiyas Maqbool, M Sudharsan, G Kanimozhi, Sara T Alrashood, Haseeb A Khan, Nagarajan Rajendra Prasad

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Journal of microbiology and biotechnology · 2022
    Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Illiyas MaqboolDepartment of Biochemistry and Biotechnology, Annamalai University, Chidambaram, India.
M SudharsanDepartment of Biochemistry and Biotechnology, Annamalai University, Chidambaram, India.
G KanimozhiDharmapuram Gnanambigai Government Arts College for Women, Mayiladuthurai, India.
Sara T AlrashoodDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Haseeb A KhanDepartment of Biochemistry, College of Sciences, King Saud University, Riyadh, Saudi Arabia.
Nagarajan Rajendra PrasadDepartment of Biochemistry and Biotechnology, Annamalai University, Chidambaram, India.
Annamalai University · INKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extremophilic organisms have the potential to tolerate extremely challenging environments of nature. This property can be accredited to its production of novel secondary metabolites that possess anticancer and other pharmaceutical values. The present study was aimed to investigate the anticancer activity of crude secondary metabolite extract (CSME) obtained from the radiation-tolerant bacterium

Indexed as

anticancer agentsapoptosisbioactive compoundsDeinococcus radioduransGC-MStriple-negative breast carcinoma

Identifiers

PMID32850827
PMCPMC7409529
OpenAlexW3046646455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.